메뉴 건너뛰기




Volumn 21, Issue 7, 2012, Pages 741-743

Risk-based secondary prevention of obstetric antiphospholipid syndrome

Author keywords

antiphospholipid antibodies; antiphospholipid syndrome; pregnancy morbidity; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; STEROID;

EID: 84861562658     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312446388     Document Type: Conference Paper
Times cited : (11)

References (19)
  • 1
    • 0021742919 scopus 로고
    • The Prosser-White oration 1983. Connective tissue disease and the skin
    • Hughes GR. The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol. 1984 ; 9: 535-544
    • (1984) Clin Exp Dermatol , vol.9 , pp. 535-544
    • Hughes, G.R.1
  • 2
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3
  • 3
    • 0034810266 scopus 로고    scopus 로고
    • Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis
    • Carmona F, Font J, Azulay M, et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am J Reprod Immunol. 2001 ; 46: 274-279
    • (2001) Am J Reprod Immunol , vol.46 , pp. 274-279
    • Carmona, F.1    Font, J.2    Azulay, M.3
  • 4
    • 67149087369 scopus 로고    scopus 로고
    • Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus
    • Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 1195-1199
    • (2009) J Rheumatol , vol.36 , pp. 1195-1199
    • Danowski, A.1    De Azevedo, M.N.2    De Souza Papi, J.A.3    Petri, M.4
  • 5
    • 33748597665 scopus 로고    scopus 로고
    • Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity
    • Ruffatti A, Tonello M, Del Ross T, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost. 2006 ; 96: 337-341
    • (2006) Thromb Haemost , vol.96 , pp. 337-341
    • Ruffatti, A.1    Tonello, M.2    Del Ross, T.3
  • 6
    • 57949106754 scopus 로고    scopus 로고
    • Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy
    • Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res. 2009 ; 123: 482-487
    • (2009) Thromb Res , vol.123 , pp. 482-487
    • Ruffatti, A.1    Tonello, M.2    Cavazzana, A.3    Bagatella, P.4    Pengo, V.5
  • 7
    • 74849134126 scopus 로고    scopus 로고
    • Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
    • Bramham K, Hunt BJ, Germain S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus. 2010 ; 19: 58-64
    • (2010) Lupus , vol.19 , pp. 58-64
    • Bramham, K.1    Hunt, B.J.2    Germain, S.3
  • 8
    • 77953323218 scopus 로고    scopus 로고
    • Predictors of pregnancy outcome in antiphospholipid syndrome: A review
    • De Carolis S, Botta A, Santucci S, et al. Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clin Rev Allergy Immunol. 2010 ; 38: 116-124
    • (2010) Clin Rev Allergy Immunol , vol.38 , pp. 116-124
    • De Carolis, S.1    Botta, A.2    Santucci, S.3
  • 9
    • 77649215763 scopus 로고    scopus 로고
    • Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome
    • Ruffatti A, Calligaro A, Hoxha A, et al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res. 2010 ; 62: 302-307
    • (2010) Arthritis Care Res , vol.62 , pp. 302-307
    • Ruffatti, A.1    Calligaro, A.2    Hoxha, A.3
  • 10
    • 0029934389 scopus 로고    scopus 로고
    • Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
    • Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996 ; 174: 1584-1589
    • (1996) Am J Obstet Gynecol , vol.174 , pp. 1584-1589
    • Kutteh, W.H.1
  • 11
    • 0031022366 scopus 로고    scopus 로고
    • Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
    • Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997 ; 314: 253-257
    • (1997) BMJ , vol.314 , pp. 253-257
    • Rai, R.1    Cohen, H.2    Dave, M.3    Regan, L.4
  • 12
    • 0036711316 scopus 로고    scopus 로고
    • Antiphospholipid syndrome in pregnancy a randomized, controlled trial of treatment
    • Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy a randomized, controlled trial of treatment. Obstet Gynecol. 2002 ; 100: 408-413
    • (2002) Obstet Gynecol , vol.100 , pp. 408-413
    • Farquharson, R.G.1    Quenby, S.2    Greaves, M.3
  • 13
    • 64849104901 scopus 로고    scopus 로고
    • Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the randomized, controlled HepASA trial
    • Laskin CA, Spitzer KA, Clark CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol. 2009 ; 36: 279-287
    • (2009) J Rheumatol , vol.36 , pp. 279-287
    • Laskin, C.A.1    Spitzer, K.A.2    Clark, C.A.3
  • 14
    • 77950377251 scopus 로고    scopus 로고
    • Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: A meta-analysis of randomized controlled trials and meta-regression
    • Mak A, Cheung MW, Cheak AA, Ho RC. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology. 2010 ; 49: 281-288
    • (2010) Rheumatology , vol.49 , pp. 281-288
    • Mak, A.1    Cheung, M.W.2    Cheak, A.A.3    Ho, R.C.4
  • 15
    • 54549099356 scopus 로고    scopus 로고
    • Management of the controversial aspects of the antiphospholipid syndrome pregnancies: A guide for clinicians and researchers
    • Erkan D, Patel S, Nuzzo M, et al. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology. 2008 ; 47: iii23 - iii27
    • (2008) Rheumatology , vol.47
    • Erkan, D.1    Patel, S.2    Nuzzo, M.3
  • 16
    • 0033979270 scopus 로고    scopus 로고
    • A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group
    • Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol. 2000 ; 182: 122-127
    • (2000) Am J Obstet Gynecol , vol.182 , pp. 122-127
    • Branch, D.W.1    Peaceman, A.M.2    Druzin, M.3
  • 17
    • 33846638644 scopus 로고    scopus 로고
    • Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome A report of 9 cases and a review of the literature
    • Ruffatti A, Marson P, Pengo V, et al. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome A report of 9 cases and a review of the literature. Autoimmun Rev. 2007 ; 6: 196-202
    • (2007) Autoimmun Rev , vol.6 , pp. 196-202
    • Ruffatti, A.1    Marson, P.2    Pengo, V.3
  • 18
    • 63349110639 scopus 로고    scopus 로고
    • Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome
    • Bortolati M, Marson P, Chiarelli S, et al. Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome. Ther Apher Dial. 2009 ; 13: 157-160
    • (2009) Ther Apher Dial , vol.13 , pp. 157-160
    • Bortolati, M.1    Marson, P.2    Chiarelli, S.3
  • 19
    • 80051936498 scopus 로고    scopus 로고
    • Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: A multicentre, case-control study
    • Ruffatti A, Tonello M, Visentin MS, et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology. 2011 ; 50: 1684-1689
    • (2011) Rheumatology , vol.50 , pp. 1684-1689
    • Ruffatti, A.1    Tonello, M.2    Visentin, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.